Adamis (ADMP) Stock Should Be Up, Not Down, Following FDA Approval, Says Analyst

Yesterday afternoon, Adamis (ADMP) announced FDA approval of its lower dose version (0.15mg) of Symjepi for treatment of anaphylaxis in pediatric patients.

Adamis Pharmaceuticals (ADMP) Provides a Business Update After Rollercoaster Month for the Stock

Adamis Pharmaceuticals (NASDAQ:ADMP) shares tumbled as much as 30% this month, prompting plenty of inquiries from investors. Dr.

Adamis Pharma (ADMP) Stock: Next Stop, $7.50?

It’s a big day for Adamis Pharma (NASDAQ:ADMP). The drug maker announced a commercial partnership for its generic EpiPe Symjepi with Novartis (NYSE:NVS) subsidiary Sandoz, …

Why Adamis (ADMP) Is Skyrocketing Today

Adamis Pharmaceuticals (NASDAQ:ADMP) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 45% upturn. …

Adamis Pharmaceuticals Corp ׁ(ADMP) In Talks With Two Potential Partners; Maxim Weighs In

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) shares are shooting up 34% faster than Jack’s magic bean sparking right into a giant beanstalk. The reason?

Adamis Pharmaceuticals Corp: Naloxone Could Be a Significant Growth Candidate, Says Elliot Wilbur

With the tremendous focus on the opioid crisis, Raymond James’ Elliot Wilbur sees exciting potential for Adamis.

Adamis Pharmaceuticals Corp (ADMP) Moves Forward with a New Opioid Overdose Drug

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) announced the submission of an Investigational New Drug (IND) application to the U.S.

Adamis Pharmaceuticals Corp (ADMP): Analyst Sees Meaningful Revenue Gains Waiting in the Wings for Sympjepi Asset

Now that ADMP has submitted a PAS for its pediatric version of Symjepi, an epipnephrine injection cheaper than Mylan’s EpiPen, FBR’s Andrew D’silva sees a potential approval with less risk than the original version.

Why Maxim Raised Price Target for Adamis Pharmaceuticals Corp

Adamis Stock Can Reach $13 as Symjepi Deal Is Imminent

A Glimpse Into Two Skyrocketing Biotechs: Celsion Corporation (CLSN), Adamis Pharmaceuticals Corp (ADMP)

Celsion Withdraws Stock Offering Celsion Corporation (NASDAQ:CLSN) shares are on a massive upswing, climbing nearly 110% in pre-market trading Friday on the heels of the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts